申请人:Axikin Pharmaceuticals, Inc.
公开号:EP2749554A2
公开(公告)日:2014-07-02
Provided herein are 2,5-disubstituted arylsulfonamide CCR3 antagonists of Formula (Ia) or (II), and pharmaceutical compositions thereof: wherein X, Y, Z, and R1 - R5 are as defined herein. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3 -mediated disorder, disease, or condition.
本文提供了式(Ia)或(II)的2,5-二取代芳基磺酰胺CCR3拮抗剂及其药物组合物:其中X、Y、Z和R1-R5如本文所定义。本文还提供了它们用于治疗、预防或改善CCR3介导的紊乱、疾病或病症的一种或多种症状的方法。